RMD: מחיר למכירות ResMed Inc
ResMed Inc. (RMD) integrates the production of lung ventilation systems with cloud services, reducing its dependence on price fluctuations. However, revenue stability relies on chip availability and insurance payouts. The price-to-sales ratio visualizes this trend, where 5.90 is recorded as the baseline value. Looking ahead, the impact of GLP-1 drugs remains merely a hypothetical risk to demand.
פילוחים אנליטיים של חברת ResMed Corp (RMD)
Steady demand for apnea therapy accessories provides ResMed Inc. (RMD) with a predictable cash flow, rendering its revenue a reliable foundation for business valuation. By analyzing the P/S chart, an investor determines the value of a single dollar of sales within the capitalization structure, identifying whether the asset is undervalued or if there is a risk of overpayment when the multiple deviates from its historical averages.
